Status:
NOT_YET_RECRUITING
High Definition Profiling of Ovarian Cancer Ascites
Lead Sponsor:
European Institute of Oncology
Conditions:
Ovarian Cancer
High Grade Ovarian Serous Adenocarcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
This project entails the collection of a prospective cohort of ascites (AS) samples from High Grade Serous Ovarian Cancer (HGSOC) patients. High Grade Serous Ovarian Cancer (HGSOC) is a major cause o...
Detailed Description
HGSOC is a major cause of cancer-related mortality, due to the late-stage diagnosis and failure of surgery and chemotherapy (CHT) to eradicate the disease with no significant improvement in overall su...
Eligibility Criteria
Inclusion
- Patients with suspicious or confirmed ovarian cancer pathology undergoing debulking surgery
- Diagnosis of high grade serous ovarian cancer confirmed by histopathology assessment
- Patients who provided written informed consent
Exclusion
- HIV-positive patients
- HBV-positive patients
- HCV-positive patients
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2033
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06553742
Start Date
November 1 2024
End Date
December 1 2033
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European Institute of Oncology
Milan, Italy